"Molecular Testing in Non-Small Cell Lung Cancer: An Overview and Update"
At the conclusion of this activity, the participant will be able to:
1. Describe common and emerging predictive and prognostic molecular biomarkers for non-small cell lung cancer (NSCLC)
2. Understand various molecular testing methodologies, especially next-generation sequencing, in NSCLC
3. Discuss clinical utility and challenges of cell-free tumor DNA testing in NSCLC